March 2023 - Page 2 of 6 - CannabisNewsWire

MondayMar 27, 2023 4:20 am

420 with CNW — New California Bill to Address THC Level Inflation

Anyone who consumed cannabis in the pre-legalization days will tell you that the drug has gotten progressively stronger over the years. Improvements in breeding and cultivation have allowed cultivars to develop strains with extremely high levels of THC (delta-9 tetrahydrocannabinol), the chemical compound that causes marijuana’s well-known “high.” With demand for products with high THC levels increasing, cultivars nationwide compete to create the most potent cannabis, resulting in an industry suffused with high-potency goods such as dabs. The proliferation of high-potency cannabis products in America’s state legal market has worried some medical experts, who are concerned that inflated THC levels…

FridayMar 24, 2023 4:20 pm

420 with CNW — Mississippi Farmers Switch from Hemp to Growing Marijuana

Mississippi approved the use of medical cannabis last year after a lengthy legislative debate, though local governments were given the option to reject the initiative. Lincoln County was one of the counties that initially declined to participate in the program. However, the decision prompted Timothy Gibson and Jason McDonald to take the lead in pushing for the legalization of medical cannabis in the county. The two succeeded in getting the issue on the ballot in August last year when county voters overturned the decision made by local officials. After the vote, they got to work on starting their own medical…

FridayMar 24, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Drug Delivery Technology Demonstrates Growing List of Potential Applications as Evidenced Through Numerous R&D Programs

DehydraTECH(TM) is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, and over-the-counter capsules, pills, tablets, topicals, oral suspensions and more The patented technology increases the speed of onset, bioavailability, brain absorption, and reduces drug administration costs Lexaria currently has multiple R&D programs – yielding successful results and further opportunities for additional study models Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, is increasing bioavailability and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented DehydraTECH(TM) technology. DehydraTECH is suitable for use…

FridayMar 24, 2023 4:20 am

420 with CNW — Analysis Finds Wisconsin Residents Bought $121M Worth of Marijuana from Illinois in 2022

A new analysis shows that residents in the state of Wisconsin bought $121.2 millions worth of cannabis from licensed retailers in Illinois last year. This contributed roughly $36 million in taxes to the neighboring state. The data was requested by Melissa Agard, the Senate Majority Leader, who asked the Legislative Fiscal Bureau to look into how much was going into Illinois through out-of-state marijuana purchases. Agard has in past sessions sponsored legalization measures. The nonpartisan bureau released its results last week after examining data obtained from the Department of Financial & Professional Regulation in Illinois, which breaks down monthly out-of-state…

ThursdayMar 23, 2023 4:20 pm

420 with CNW — Kentucky Senate Approves Medical Cannabis Legalization Bill

The Kentucky Senate recently passed medical cannabis legislation, just in time for the bill to advance to the House of Representatives. The move comes two days after the bill, SB 47, was approved by the Senate Licensing and Occupations Committee. Previously, a bill to legalize medical marijuana was passed by the House last year and in a previous session, but the Senate did not take any action on those bills. Thus, proponents began working on the Senate side this session to improve the bill's chances of passage. Some provisions of the measure include: Patients with severe pain, cancer, epilepsy, muscle…

ThursdayMar 23, 2023 4:20 am

420 with CNW — Kentucky Legislators Approve Medical Cannabis Bill

After years of hitting a brick wall, proponents of medical cannabis legalization in Kentucky have made progress when their legislation won support from a significant Republican leader and passed a Senate committee. Applause broke out from supporters when Senate Majority Leader Damon Thayer changed his vote from opposing the legislation to supporting it. Thayer approved the specific objectives of the bill and stated that he supported it because of those who were suffering. During the bill debate, opponents of the measure sympathized with those who experienced chronic pain and other conditions, but they cautioned that marijuana use could be addictive…

WednesdayMar 22, 2023 4:20 pm

420 with CNW — Cannabis Legalization Bill in Minnesota Sees Major Overhaul

Earlier this year, a Minnesota House committee approved a measure to legalize recreational cannabis for adults in the state. The legislation was an updated version of a recreational cannabis bill that had advanced from the Minnesota House but failed to pass the then-Republican-controlled Senate. Once it was approved, the bill was set to be scrutinized by more than 10 committees in the House before heading to the Senate. The recreational cannabis measure recently got a major overhaul and was amended to include new language to protect Minnesota’s nascent low-potency drinkables and edibles segment. Low-potency cannabis products are made using THC…

WednesdayMar 22, 2023 4:20 am

420 with CNW — German Minister Confident That EU Will Sign Off on Germany’s Adult-Use Cannabis Proposals

Last year, German lawmakers unveiled a measure that would legalize recreational cannabis in the country. The bill would allow adults aged 21 years and older to purchase and possess up to 30 grams of cannabis for personal use as well as legalize the home cultivation of up to three mature cannabis plants per adult. Speaking at the time, Health Minister Karl Lauterbach said that the measure would help to protect the country’s young people as the current ban on recreational cannabis had proven to be ineffective. Although the measure still hadn’t received parliamentary approval at the time, the largest hurdle…

TuesdayMar 21, 2023 4:20 pm

420 with CNW — Synthetic Cannabinoids Drive Wedge Between Hemp, Marijuana Industries

Gold Spectrum, a hemp company based in Tennessee, is the most recent company to introduce a new line of edibles called Delta 8+ THC-O Cereal Bars, widening the rift between the hemp and marijuana industries. Since the 2018 farm bill's passage, delta-8 THC has gained widespread acceptance as a marijuana substitute in states where it is illegal, including Tennessee. THC-O is a relatively recent discovery; it is a synthetic cannabinoid produced through chemical synthesis that packs an intoxicating punch. It is also not covered by the farm bill such as naturally occurring cannabinoids derived from hemp. However, a growing number…

TuesdayMar 21, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Tracking Proprietary Path to Drug Delivery Innovation and Commercialization on Robust R&D Programs

Lexaria Bioscience is a global innovator in drug delivery platforms The company has been developing and commercializing patented DehydraTECH(TM), a technology that has been shown to increase the bioavailability of fat-soluble active molecules, improve the speed of onset and provide other benefits across multiple applications Lexaria has undertaken numerous R&D programs in an effort to build relationships with prospective corporate partners to out-license the technology or to form other profitable corporate relationships The company owes its achievements to its focus on R&D and the guidance provided by its highly experienced leadership, including CEO Chris Bunka, President John Docherty, as well…